Federal prosecutors have charged Indivior with engaging in a multibillion-dollar fraudulent scheme to increase prescriptions of Suboxone Film, a medicine used to treat addiction to opioid and narcotics.

In an indictment filed on Wednesday, the Justice Department alleged the drug maker deceived doctors and payers into believing the medicine was safer and less prone to diversion and abuse than other such treatments, although the company lacked any scientific evidence to support those claims. The indictment also claimed the company used a telephone and Internet program to connect patients struggling with addiction to doctors who were inappropriately prescribing opioids and at high rates.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy